A new treatment for endometriosis targets the cause and not the symptoms
The endometrium, the innermost lining of the uterus, plays a starring role in the menstrual cycle, implantation of the embryo and development of the placenta. Globally, about 1 in 10 women of reproductive age suffer from endometriosis, an often painful disorder in which tissue similar to the endometrium grows outside the uterus. The tissue acts much like the endometrium, thickening, breaking down and bleeding with each menstrual cycle. However, unlike the endometrium, this tissue has nowhere to go and can irritate surrounding tissue, eventually forming scars and adhesions, resulting in pain and/or infertility. Diagnosis is often delayed; treatment ameliorates symptoms but there is no cure. The EU-funded EndoSolve project is developing a pioneering medical device targeting the mechanisms of development that promises a long-term solution for millions of women.
Funding SchemeERC-POC-LS - ERC Proof of Concept Lump Sum Pilot
See on map